BAYER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bayer, and what generic alternatives are available?
Bayer is a drug marketed by Bayer and is included in one NDA.
The generic ingredient in BAYER is aspirin. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BAYER?
- What are the global sales for BAYER?
- What is Average Wholesale Price for BAYER?
Summary for BAYER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Sales Revenues: | Drug sales revenues for BAYER |
| DailyMed Link: | BAYER at DailyMed |
US Patents and Regulatory Information for BAYER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer | BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN | aspirin | TABLET;ORAL | 021317-001 | Oct 18, 2001 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
